Clinical research - Press Releases

Date	Title	Company
17-Oct-2021	SMi's 4th Annual Ophthalmic Drugs Conference - Chairman's Invitation Released	Ophthalmic Drugs
12-Oct-2021	Targeted reduction of SARS-COV-2 viral load in the nose with photodisinfection may reduce severity of lower tract respiratory disease	Ondine Biomedical
07-Oct-2021	New Elsevier report highlights progress towards disease-modifying treatments for pancreatitis	Elsevier
06-Oct-2021	Transgene and BioInvent to present preclinical data on BT-001 oncolytic virus at SITC 2021	Transgene
06-Oct-2021	Pistoia Alliance President Warns Pharmaceutical Industry Not to Undo the Advances it has Made During the Pandemic	The Pistoia Alliance
05-Oct-2021	New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA® (ustekinumab) in Older Patients Across Approved Indications	Janssen
30-Sep-2021	NEW RESEARCH SHOWS PROBIOTIC SUPPLEMENTATION CAN PREVENT MASTITIS IN BREASTFEEDING MOTHERS	Nutricia Early Life Nutrition
30-Sep-2021	LEO Pharma presents new Adtralza®▼ (tralokinumab) data following long-term continuous treatment at EADV 30th Congress	LEO Pharma
29-Sep-2021	£2.7M CHALLENGE SET TO REPLACE USE OF DOGS IN DRUG TESTING	konfer
28-Sep-2021	Artios Doses First Patient in Phase 1/2a Study of Polθ Inhibitor ART4215	Arix Bioscience plc
28-Sep-2021	LTI and eClinicalHealth Form Strategic Partnership to Accelerate Innovation in Clinical Research	LTI and eClinicalHealth
23-Sep-2021	Tánaiste announces multi-million Euro R&D support of ICON to accelerate decentralised clinical trial technology	ICON
23-Sep-2021	Veterinary Health Research Centers Launches Clinical Research Programs For Animal Health, Pharma and Medical Device Companies	Veterinary Health Research Centers
22-Sep-2021	Velocity Clinical Research’s multi-site acquisitions signal new frontier for clinical site management industry	Velocity Clinical Research
20-Sep-2021	Janssen Presents Results from Phase 1b/2 NORSE Study in Patients with Metastatic or Locally Advanced Urothelial Carcinoma Treated with Erdafitinib in Combination with Cetrelimab, a PD-1 Inhibitor	The Janssen Pharmaceutical Companies of Johnson & Johnson
20-Sep-2021	Leading Microbiologists to meet at SMi’s 10th Annual Pharmaceutical Microbiology Conference	SMi Group
20-Sep-2021	Novartis unveils new data at ESMO 2021, including compelling longest ever reported median overall survival data in advanced breast cancer, as it continues to push the boundaries of innovation	Novartis
16-Sep-2021	Pharmapack Report 2021: US leads on drug device innovation but trails Europe on sustainability	Pharmapack Europe
15-Sep-2021	Perception Neuroscience Initiates Phase 2a Study of PCN-101 (R-ketamine) for Treatment Resistant Depression	Perception Neuroscience
10-Sep-2021	PureTech Founded Entity Vor Biopharma Announces VOR33 Granted U.S. FDA Fast Track Designation for Acute Myeloid Leukemia	PureTech Health plc